AG
HBIO icon

Advisor Group’s Harvard Bioscience HBIO Stock Holding History

Advisor Group’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
67
– – ﹤0.01% 4980
2019
Q3 		$2K Hold
67
– – ﹤0.01% 4965
2019
Q2 		$1K Buy
67
+17
+34% +$498 ﹤0.01% 5108
2019
Q1 		$2K Buy
+50
New +$1.81K ﹤0.01% 4951

Other funds holding HBIO

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.46B AUM 78.13% 1-Year Est. Return

Advisor Group's HBIO Position: Q4 2019 in Review

Advisor Group held its Harvard Bioscience (HBIO) position steady in Q4 2019 at 67 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4980.

Advisor Group first reported a position in HBIO in Q1 2019 and has held it in 4 quarters since. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2019.

  • Advisor Group held 67 shares of Harvard Bioscience worth $2K as of Q4 2019.
  • Advisor Group left its Harvard Bioscience share count unchanged in Q4 2019.
  • Harvard Bioscience made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4980 holding.
  • Advisor Group first reported a position in Harvard Bioscience in Q1 2019 and has held it in 4 quarters since.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.